Ethan Zohn doing well on Adcetris


According to a profile in People magazine, Survivor winner Ethan Zohn is doing well on Adcetris (SGN-35), the treatment he's receiving for relapsed Hodgkin's lymphoma.

After three rounds of the treatment, Zohn said "I'm responding very well to the drug. My tumors are reducing. It's not a 100-percent reduction, but my doctor gave me an A-minus so I'll take it."

Zohn ran the New York City Marathon in November, finishing in 4 hours 20 minutes, and more recently ran the Walt Disney World Half Marathon. Next he intends to take part in a cycling event to raise money for the Memorial Sloan-Kettering Cancer Center in New York.

Eventually Zohn will be tested for a possible stem-cell transplant.

Source: People

LymphomaInfo Social